News Release 2014 December 1, 2014 Release of Flutiform® 50 Aerosol - 120 inhalations, Flutiform® 125 Aerosol - 120 inhalations , a combination drug for asthma treatment November 27, 2014 Signing of Co-Marketing Agreement on Investigational Antiallergic Agent, Desloratadine for Japan October 10, 2014 Kyorin Pharmaceutical and R-Pharm Reach Agreement in Russia and neighboring nations for Activities Related to the Development and Marketing of Imidafenacin September 10, 2014 EISAI AND KYORIN ENTER INTO AGREEMENT CONCERNING COMPOUND LIBRARY USE FOR THE DEVELOPMENT OF NEW ANTIBACTERIAL AGENTS July 22, 2014 Kyorin signed a License Agreement with Merck on Vibegron for Overactive Bladder in Japan July 1, 2014 Gene-Therapy Product for the Treatment of Malignant Pleural Mesothelioma adopted as Next generation Technology Transfer Program (NexTEP) by JST 1
